Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1988 Nov;64(757):883–885. doi: 10.1136/pgmj.64.757.883

Non-Hodgkin's lymphoma presenting as 'chronic active toxoplasmosis'.

N J Dudley 1, A H Balfour 1
PMCID: PMC2429068  PMID: 3255940

Abstract

We report the case of a 58 year old man in whom an unusually prolonged infection with Toxoplasma gondii was the presenting feature of an underlying non-Hodgkin's lymphoma. This case demonstrates the particular usefulness of the IgM ELISA test in monitoring disease activity.

Full text

PDF
884

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C., LESKOWITZ S. Antibody formation in Hodgkin's disease. N Engl J Med. 1963 Jun 6;268:1269–1272. doi: 10.1056/NEJM196306062682304. [DOI] [PubMed] [Google Scholar]
  2. Aisenberg A. C. Manifestations of immunologic unresponsiveness in Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1152–1164. [PubMed] [Google Scholar]
  3. Bogusławska-Jaworska J., Pisarek J., Chybicka A. Toxoplasmosis in the course of neoplastic diseases of haematopoietic and lymphatic system in children. Mater Med Pol. 1982 Jan-Dec;14(1-2):62–67. [PubMed] [Google Scholar]
  4. Frenkel J. K. Immunity in toxoplasmosis. Bull Pan Am Health Organ. 1985;19(4):354–367. [PubMed] [Google Scholar]
  5. Green J. A., Spruance S. L., Cheson B. D. Favorable outcome of central nervous system toxoplasmosis occurring in a patient with untreated Hodgkin's disease. Cancer. 1980 Feb 15;45(4):808–810. doi: 10.1002/1097-0142(19800215)45:4<808::aid-cncr2820450433>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  6. Hakes T. B., Armstrong D. Toxoplasmosis. Problems in diagnosis and treatment. Cancer. 1983 Oct 15;52(8):1535–1540. doi: 10.1002/1097-0142(19831015)52:8<1535::aid-cncr2820520833>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Hancock B. W., Bruce L., Sugden P., Ward A. M., Richmond J. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study. Clin Oncol. 1977 Mar;3(1):57–63. [PubMed] [Google Scholar]
  8. Hancock B. W., Bruce L., Ward A. M., Richmond J. The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma. Clin Oncol. 1977 Jun;3(2):137–144. [PubMed] [Google Scholar]
  9. Hersh E. M., Oppenheim J. J. Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med. 1965 Nov 4;273(19):1006–1012. doi: 10.1056/NEJM196511042731903. [DOI] [PubMed] [Google Scholar]
  10. Krick J. A., Remington J. S. Toxoplasmosis in the adult--an overview. N Engl J Med. 1978 Mar 9;298(10):550–553. doi: 10.1056/NEJM197803092981006. [DOI] [PubMed] [Google Scholar]
  11. Payne R. A., Joynson D. H., Balfour A. H., Harford J. P., Fleck D. G., Mythen M., Saunders R. J. Public Health Laboratory Service enzyme linked immunosorbent assay for detecting Toxoplasma specific IgM antibody. J Clin Pathol. 1987 Mar;40(3):276–281. doi: 10.1136/jcp.40.3.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ruskin J., Remington J. S. Toxoplasmosis in the compromised host. Ann Intern Med. 1976 Feb;84(2):193–199. doi: 10.7326/0003-4819-84-2-193. [DOI] [PubMed] [Google Scholar]
  13. Sabin A. B., Feldman H. A. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science. 1948 Dec 10;108(2815):660–663. doi: 10.1126/science.108.2815.660. [DOI] [PubMed] [Google Scholar]
  14. Siber G. R., Weitzman S. A., Aisenberg A. C., Weinstein H. J., Schiffman G. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med. 1978 Aug 31;299(9):442–448. doi: 10.1056/NEJM197808312990903. [DOI] [PubMed] [Google Scholar]
  15. Slavick H. E., Lipman I. J. Brain stem toxoplasmosis complicating Hodgkin's disease. Arch Neurol. 1977 Oct;34(10):636–637. doi: 10.1001/archneur.1977.00500220070013. [DOI] [PubMed] [Google Scholar]
  16. Smith G. M., Leyland M. J., Crocker J., Geddes A. M. Cerebral toxoplasmosis in a patient with Hodgkin's disease. J Infect. 1987 May;14(3):243–245. doi: 10.1016/s0163-4453(87)93510-9. [DOI] [PubMed] [Google Scholar]
  17. Vietzke W. M., Gelderman A. H., Grimley P. M., Valsamis M. P. Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute. Cancer. 1968 May;21(5):816–827. doi: 10.1002/1097-0142(196805)21:5<816::aid-cncr2820210506>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  18. Young R. C., Corder M. P., Haynes H. A., DeVita V. T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972 Jan;52(1):63–72. doi: 10.1016/0002-9343(72)90008-3. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES